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ABSTRACT
Cell division controls the faithful segregation of genomic and
cytoplasmic materials between the two nascent daughter cells.
Members of the Aurora, Polo and cyclin-dependent (Cdk) kinase
families are known to regulate multiple events throughout cell
division, whereas another kinase, citron kinase (CIT-K), for a long
time has been considered to function solely during cytokinesis, the
last phase of cell division. CIT-K was originally proposed to regulate
the ingression of the cleavage furrow that forms at the equatorial
cortex of the dividing cell after chromosome segregation. However,
studies in the last decade have clarified that this kinase is, instead,
required for the organization of the midbody in late cytokinesis, and
also revealed novel functions of CIT-K earlier in mitosis and in DNA
damage control. Moreover, CIT-K mutations have recently been
linked to the development of human microcephaly, and CIT-K has
been identified as a potential target in cancer therapy. In this
Commentary, I describe and re-evaluate the functions and regulation
of CIT-K during cell division and its involvement in human disease.
Finally, I offer my perspectives on the open questions and future
challenges that are necessary to address, in order to fully understand
this important and yet unjustly neglected mitotic kinase.
KEY WORDS: Citron kinase, Cell division, Spindle orientation,
Polyploidy, Microcephaly, Cancer
Introduction
The fascinating process of cell division is essential for growth,
development and reproduction in many organisms. Cell division
controls the correct segregation of genome and cytoplasm,
including organelles, into daughter cells. In addition, the
orientation of the plane of division is crucial for determining cell
fate and tissue organization. It is, therefore, not surprising that errors
in this process have been implicated in many human diseases,
including chromosomal syndromes, microcephaly, sterility and
cancer. Complex control and surveillance mechanisms have
evolved to ensure the fidelity and robustness of mitotic and
meiotic processes. As the chromatin is highly compacted during cell
division, these mechanisms rely in large part on post-translational
modifications (PTMs) of proteins involved in the assembly and
orientation of the mitotic spindle (Prosser and Pelletier, 2017), the
attachment and segregation of chromosomes (Musacchio, 2015;
Musacchio and Desai, 2017), and the formation and ingression of a
cleavage furrow that separates the two daughter cells (Fig. 1)
(D’Avino et al., 2015). Two types of PTM are mainly used to
regulate cell division, ubiquitylation and phosphorylation/de-
phosphorylation. Ubiquitin-mediated protein degradation helps to
ensure accurate, timely and unidirectional progression through
different stages of mitosis and meiosis, whereas phosphorylation/
de-phosphorylation controls the activity, localization and
interactions of a wide variety of mitotic factors. Members of the
Aurora, Polo and cyclin-dependent (Cdk) kinase families regulate
many mitotic events by phosphorylating a plethora of proteins
(Archambault and Glover, 2009; Carmena et al., 2012; Malumbres,
2014). Other kinases have, instead, been described to have a more
‘restricted’ role and to act only during specific phases of cell
division. One of these kinases is Citron kinase (CIT-K; gene name
CIT) that, for a long time, has been considered to function only
during the last phase of cell division, i.e. during cytokinesis. CIT-K
was originally identified as a binding partner of active forms of the
small GTPases Rho and Rac (Di Cunto et al., 1998; Madaule et al.,
1995). It was later proposed to promote the constriction of the
actomyosin contractile ring that drives cleavage furrow ingression
during cytokinesis by phosphorylating the myosin regulatory light
chain (MRLC) (Madaule et al., 1998, 2000; Yamashiro et al., 2003).
Subsequent studies, however, have revealed that, instead, CIT-K has
an evolutionarily conserved role in later stages of cytokinesis, after
completion of furrow ingression (Bassi et al., 2011, 2013; D’Avino
et al., 2004; Echard et al., 2004; Gai et al., 2011; Gruneberg et al.,
2006; McKenzie et al., 2016; Naim et al., 2004; Shandala et al.,
2004; Watanabe et al., 2013), and recent evidence indicates that
CIT-K is also important in early mitosis (Gai et al., 2016).
Furthermore, mutations in CIT-K have been recently found to cause
human primary microcephaly, and this kinase has been proposed as
a target in anti-cancer therapy (Basit et al., 2016; Fu et al., 2011;
Harding et al., 2016; Li et al., 2016; McKenzie and D’Avino, 2016;
Shaheen et al., 2016). Finally, there is growing evidence that CIT-K
is subject to multiple levels of regulation by both intra- and extra-
cellular mechanisms (Jungas et al., 2016; McKenzie et al., 2016).
These studies clearly indicate that CIT-K has a much more
important role in cell division and human disease than previously
thought, suggesting this kinase has been unjustly neglected and
misunderstood for a long time. To rectify this, in this Commentary, I
review what is known about the functions of CIT-K in cell division,
how it is regulated by other signalling molecules, as well as its
implication in human disease, before offering my views on the
unanswered questions and future challenges that need yet to be
tackled in order to fully understand this multifaceted and important
mitotic kinase.
CIT-K functions in cell division: cytokinesis and beyond
CIT-K is a large – >2000 amino acids long –multifunctional protein
with a complex structure. It contains an N-terminal kinase domain;
two central coiled-coil domains (CC1 and CC2), with the latter
harbouring a Rho/Rac binding domain (RBD); a cysteine-rich (C1)
motif that is adjacent to a pleckstrin homology (PH) domain, and a
Citron−Nik1 homology (CNH) domain in the C-terminus
(Fig. 2A). Two different CIT isoforms, CIT-K and CIT-N, have
been described in mammals, with CIT-N being shorter and lacking
the kinase domain (Di Cunto et al., 1998; Madaule et al., 1998).
CIT-K is expressed throughout the cell cycle. It is uniformly
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distributed within the cytoplasm during interphase (Eda et al., 2001)
but, during cell division, is enriched at the spindle poles during
metaphase (Gai et al., 2016) before accumulation increases
substantially at the cleavage furrow after onset of anaphase (Eda
et al., 2001; Madaule et al., 1998). After completion of furrowing,
CIT-K forms a ring at the midbody, an organelle located at the
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Fig. 1. Schematic representation of the cell cycle with indicated roles of CIT-K. Microtubules are depicted in blue, DNA/chromosomes in grey and
kinetochores, actomyosin contractile ring and midbody in red. The different populations of microtubules are also indicated. A magnification of the midbody is
shown during late telophase to illustrate its different regions. For a complete description of the midbody, please see D’Avino and Capalbo, 2016.
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Fig. 2. Structure and localization of CIT-K. (A) Schematic diagram of CIT-K protein domains: Kinase, kinase domain; CC1, coiled-coil region 1; CC2 coiled-coil
region 2; RBD, Rho-binding domain; C1, cysteine-rich motif; PH, pleckstrin-homology domain; CNH, Citron–Nik1 homology domain. (B) Human HeLa cells stably
expressing a Flag-tagged CIT-K transgene were fixed and stained to detect Flag (red), tubulin (green) and DNA (blue). Scale bars: 10 µm. Adapted with
permission from McKenzie et al., 2016, where it was published under a CC-BY licence (https://creativecommons.org/licenses/by/4.0/). (C) Midbodies were
purified from HeLa cells and fixed and stained, to detect CIT-K (green) and tubulin (red); notice the ring-like distribution of CIT-K.
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centre of the intercellular bridge that acts as a platform for the
recruitment of proteins required for the final separation – i.e.
abscission – of the two daughter cells (Fig. 2B and C) (D’Avino and
Capalbo, 2016; Eda et al., 2001; Gai et al., 2011; Hu et al., 2012;
McKenzie et al., 2016;Watanabe et al., 2013). A pool of CIT-K also
accumulates at the central spindle, an array of antiparallel and
interdigitating microtubules that assemble between the segregating
chromosomes during anaphase (Fig. 2B) (Eda et al., 2001;
McKenzie et al., 2016; Paramasivam et al., 2007). An identical
localization to the cleavage furrow and to the midbody has also been
reported for the Drosophila CIT-K ortholog Sticky (Sti) (Bassi
et al., 2013; D’Avino et al., 2004; Naim et al., 2004; Shandala et al.,
2004). However, it is not yet known whether Sti accumulates at the
spindle poles during metaphase, despite the fact that the functions of
CIT-K during metaphase appear to be conserved in both human and
fly cells (Gai et al., 2016). Initial reports more than a decade ago
indicated that CIT-K has a role in the contraction of the actomyosin
ring by phosphorylating MRLC (Madaule et al., 1998, 2000;
Yamashiro et al., 2003). However, these studies were solely on the
basis of CIT-K overexpression and in vitro experiments, and were
challenged by the findings that, in Drosophila, depletion or
mutations of the sti gene caused failure of cytokinesis at a late
stage, i.e. after completion of furrow ingression (D’Avino et al.,
2004; Echard et al., 2004; Naim et al., 2004; Shandala et al., 2004).
Later studies confirmed a similar function for CIT-K in human cells
and highlighted its role in the organization of the midbody and in
abscission (Bassi et al., 2011, 2013; Gai et al., 2011; McKenzie
et al., 2016; Watanabe et al., 2013).
The midbody is composed of several proteins localized to the
preceding contractile ring and central spindle that show a very precise
and stereotypic distribution (Hu et al., 2012; Mierzwa and Gerlich,
2014). Proteomics-based approaches, as well in vivo and in vitro
binding assays, have indicated that CIT-K has an evolutionarily
conserved role inmidbodyorganization by linking components of the
contractile ring and central spindle, including anillin, myosin, RhoA,
KIF23/MKLP1, KIF14 and the chromosomal passenger complex
(CPC) − of which Aurora B is the kinase component − and by
maintaining the correct arrangement of midbody proteins (Bassi
et al., 2011, 2013; Gai et al., 2011; Gruneberg et al., 2006; McKenzie
et al., 2016). Thus, a current model is that CIT-K does not promote
furrow ingression through MRLC phosphorylation but that – owing
to its modular structure – it, instead, acts as an organizing centre for
the midbody (Fig. 3). In the absence of CIT-K, the highly ordered
arrangement of midbody proteins and the connection between the
cortex and the central spindle microtubules are lost, which in turn
leads to abscission failure (McKenzie et al., 2016). Another
additional mechanism by which CIT-K can contribute to the
stabilization of midbody microtubules is by indirectly altering the
phosphorylation of tubulin beta III (TUBB3) (Sgrò et al., 2016). CIT-
K is necessary for the recruitment of casein kinase 2 alpha (CK2α) at
the midbody, which in turn phosphorylates TUBB3 to stabilize
microtubules.
There had been no evidence for a role of CIT-K in other mitotic
events besides cytokinesis, until a recent study reported that it is also
required for the orientation of the mitotic spindle during metaphase
(Gai et al., 2016); this work used as a starting point the previous
finding that CIT-K interacts with the abnormal spindle-like
microcephaly-associated (ASPM) protein, which is the ortholog
of the Drosophila abnormal spindle protein (Asp) (Paramasivam
et al., 2007). Asp/ASPM associates with the minus ends of
microtubules and localizes to the spindle poles during metaphase,
and to the central spindle after anaphase onset; thus, pointing to an
important role in the organization and polymerization of spindle
microtubules throughout cell division (do Carmo Avides and
Glover, 1999; Higgins et al., 2010; Saunders et al., 1997; Wakefield
et al., 2001). Gai et al. now found that CIT-K accumulates at the
spindle poles during metaphase and is necessary for the orientation
of the mitotic spindle in human, mouse and fly cells (Gai et al.,
2016). Both events depend on the interaction of CIT-K with ASPM,
and the latter also requires its kinase activity. Furthermore, the
authors also showed that CIT-K can regulate the nucleation, length
and stability of astral microtubules (Gai et al., 2016).
Although the exact molecular mechanisms by which CIT-K
regulates spindle orientation and microtubule dynamics still need to
be elucidated, these recent findings clearly demonstrate that the
roles of CIT-K in cell division have been underestimated and
overlooked. Moreover, as discussed in the next paragraph, there is
growing evidence that CIT-K is subject to multiple levels of
regulation, which suggests that the activity and function of this
kinase is tightly controlled, thus, further underscoring its
importance in cell division.
CIT-K regulation by Rho GTPases, mitotic kinases and
ephrin/ephrin receptor signalling
As mentioned above, CIT-K was initially identified as a protein
interacting with active, GTP-bound forms of Rho and Rac GTPases
(Madaule et al., 1995). This led to the obvious hypothesis that
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Fig. 3. Cartoon illustrating the interactions of CIT-K at the midbody. The
centralspindlin complex is a heterotetramer composed of two subunits of
MKLP1 and two subunits of RacGAP1. The chromosomal passenger
complex (CPC) is composed of four subunits: the kinase Aurora B, the
scaffold subunit INCENP, the cell division cycle-associated protein Borealin
and the apoptosis inhibitor protein Survivin (also known as BIRC5). Red
arrows indicate (1) phosphorylation of the INCENP TSS motif within the
CPC by CIT-K and (2) phosphorylation of the CIT-K CC1 and C1 domains of
by the CPC component Aurora B. The figure has been adapted from
McKenzie et al., 2016 where it was published under a CC-BY licence
(https://creativecommons.org/licenses/by/4.0/).
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CIT-K is a Rho/Rac effector and, subsequently, the proposition that
RhoA activates CIT-K during cytokinesis to promote the
constriction of the actomyosin ring by mediating MRLC
phosphorylation, similarly to the role of the closely related Rho
kinase (ROCK) (Madaule et al., 2000). However, clear evidence
that Rho GTPases can, indeed, activate CIT-K is still lacking,
mainly owing to the challenge in designing an assay, either in vitro
or in vivo, to test the possible ‘activation’ of this large and complex
kinase. Furthermore, the paucity of demonstrated CIT-K substrates
also makes it difficult to test whether its kinase activity is possibly
promoted by Rho GTPases. Indeed, only a single bona fide substrate
of CIT-K has been identified thus far, the inner centromere protein
(INCENP) component of the CPC; but, unfortunately, the site in
INCENP that is phosphorylated by CIT-K is also targeted by the
CPC component Aurora B, further adding to the difficulty in
assessing CIT-K activity in vivo (McKenzie et al., 2016). Moreover,
the RBD domain does not appear to be evolutionarily conserved
because the Drosophila RhoA homologue Rho1 interacts with the
CNH domain of Sti (Bassi et al., 2011; Shandala et al., 2004). It was
initially reported that RhoA is necessary for the recruitment of CIT-
K to the cleavage furrow in human cells (Eda et al., 2001). However,
this is likely to be an indirect effect because of evidence in
Drosophila that Sti is recruited to the cleavage furrow through its
association with actomyosin filaments (Bassi et al., 2011). Finally,
CIT-K is required for correct RhoA localization at the cleavage site
during late cytokinesis in both Drosophila and human cells,
indicating that CIT-K behaves more like a RhoA regulator than an
effector (Bassi et al., 2011; Gai et al., 2011; Watanabe et al., 2013).
Therefore, the relationship between RhoA and CIT-K appears less
straightforward than initially anticipated.
There is also clear evidence emerging that CIT-K is subject to
complex phosphorylation-mediated regulation by both intra- and
extra-cellular signalling pathways. Various studies, based on either
large-scale or CIT-K-focused phospho-proteomics analyses, have
identified several phosphorylation sites distributed across the entire
protein (Jungas et al., 2016; McKenzie et al., 2016; McKenzie and
D’Avino, 2016) (see also the PhosphoSitePlus database, http://
www.phosphosite.org/, for a full list of phosphorylated CIT-K
residues). Many phosphorylated residues match the consensus
sequence of other mitotic serine/threonine kinases, including
Aurora B, Cdk1 and Plk1, and my group has recently confirmed
that CIT-K is a direct substrate of both Aurora B and Cdk1
(McKenzie et al., 2016; and Zuni Irma Bassi and P.P. D’A.
unpublished data). Although the effect of Cdk1-mediated CIT-K
phosphorylation is still unclear, we have found that Aurora B and
CIT-K crossregulate each other, and that this regulatory mechanism
is important for the organization of the midbody (McKenzie et al.,
2016). CIT-K is required for the correct localization of the CPC at
the midbody and directly binds to at least three CPC components,
Aurora B, Borealin (also known as CDCA8) and INCENP. In
addition, CIT-K phosphorylates INCENP at a threonine–serine–
serine (TSS) motif that is required for Aurora B activation, thereby
promoting full activation of Aurora B. Reciprocally, Aurora B also
controls CIT-K localization and phosphorylates CIT-K within its
CC1 and C1 domains (see Fig. 2A) (McKenzie et al., 2016). The
function of the C1 domain of CIT-K has not been characterized but it
is likely to mediate its association with membrane phospholipids,
similarly to the role of the C1 domain of RacGAP1 (also known as
MgcRacGAP), a subunit of the centralspindlin complex (Lekomtsev
et al., 2012). This suggests that Aurora B regulates the interaction of
CIT-K with the plasma membrane but further studies are needed to
define such a regulative mechanism. In our recent work, we have
established that Aurora B-mediated phosphorylation of the CC1
domain prevents accumulation of CIT-K at the spindle midzone in
early cytokinesis by inhibiting its interaction with the central spindle
proteinMKLP1 (also known as KIF23) – themotor component of the
centralspindlin complex – and the CPC itself (McKenzie et al., 2016).
We have proposed that this acts as a mechanism to temporally
regulate the transition from central spindle to midbody (McKenzie
et al., 2016). In the early stages of cytokinesis, whenAurora B, CIT-K
and MKLP1 colocalize to the spindle midzone, Aurora-B-mediated
phosphorylation of CIT-Kwould inhibit a strong association between
CIT-K and MKLP1 during furrow ingression in order to not interfere
with the clustering of centralspindlin, which is also promoted by
Aurora B and necessary for the bundling of central spindle
microtubules (Fig. 4A) (Douglas et al., 2010). However, after
furrow completion, Aurora B accumulates at the midbody arms,
parting from CIT-K and MKLP1 that, instead, localize to the
Flemming body (Fig. 4B) (D’Avino and Capalbo, 2016; McKenzie
et al., 2016). Because of this separation, Aurora B is likely to have less
effect on CIT-K, allowing it to strongly bind to MKLP1 and stabilize
the midbody (Fig. 4B).
It is less straightforward to speculate on the possible role of CIT-
K-mediated activation of Aurora B through phosphorylation of
INCENP. One simple hypothesis is that this is a regulatory feedback
loop to both reinforce Aurora B activity and prevent CIT-K
accumulation at the spindle midzone during furrow ingression
(Fig. 4). However, the evidence that CIT-K and the CPC are both
required for midbody organization and for the orderly arrangement
of midbody proteins (McKenzie et al., 2016) suggests that CIT-K
and CPC also cooperate during late cytokinesis, and that this
crossregulatory mechanism is important to establish different
‘identities’ in distinct regions of the midbody.
CIT-K has also recently been found to be regulated by
extracellular signals (Jungas et al., 2016), as activation of the
Ephrin/ephrin receptor (Eph) signalling pathway, which is known to
regulate cell adhesion, causes persistent midbody and cytokinesis
failure. Jungas and colleagues reported that CIT-K failed to form a
distinct ring and showed diffuse distribution at the midbody after
activation of Ephrin/Eph signalling through the EphB2 receptor.
The authors also showed that CIT-K is directly phosphorylated by
Src kinase in EphB2-activated cells and that Src-mediated
phosphorylation of the RBD of CIT-K promotes its association
with active RhoA (Jungas et al., 2016). On the basis of these data,
the authors speculated that Ephrin/EphB2 forward-signalling
interferes with cytokinesis by promoting the association of CIT-K
with active RhoA. This association might prevent RhoA
inactivation during late cytokinesis, an event necessary for the
disassembly of the contractile ring and subsequent abscission.
However, this mechanism does not fully explain the abnormal
localization of CIT-K in EphB2-activated cells and why a CIT-K
fragment containing only the C1 domain – which is not
phosphorylated by Src, can rescue the EphB2-induced cytokinesis
defects (Jungas et al., 2016). Consistent with this, Src kinase was
shown to be able to phosphorylate several CIT-K residues outside
the RBD in vitro (Jungas et al., 2016). Thus, further analysis is
necessary to fully understand the regulation of CIT-K by Ephrin/
EphB2 signalling. The exact scope of such Ephrin/EphB2-mediated
regulation of CIT-K in the context of whole tissues is not
completely clear. Loss of Ephrin/Eph signalling in mouse neural
progenitors results in a reduction of polyploid neurons in the
neocortex, which was proposed to be achieved by affecting the
function of CIT-K during cytokinesis (Jungas et al., 2016).
However, as the role of Ephrin/Eph signalling is established in
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cell adhesion, it is also tempting to speculate that EphB2-mediated
regulation of CIT-K contributes to control the adhesion of dividing
cells to their neighbours during the dramatic cell shape changes that
occur during cytokinesis. Finally, because Src kinase is involved in
many signalling pathways that are activated by plasma membrane
receptors, multiple pathways might converge to regulate CIT-K.
To conclude, it is evident that many signalling events are able to
affect CIT-K, suggesting that the activity, localization and functions
of this kinase need to be precisely regulated. Therefore, it did not
come as a total surprise that, as discussed below, deregulation and
loss of CIT-K were recently found to be involved in human diseases
(Basit et al., 2016; Harding et al., 2016; Li et al., 2016; Shaheen
et al., 2016).
CIT-K and disease
Early findings that CIT-K-knockout mice show growth delay,
reduced life span, ataxia and defective neurogenesis (Di Cunto et al.,
2000), and that a CIT mutation in rat affects brain development
(Sarkisian et al., 2002) led to the hypothesis that CIT-K has a
particularly important role in the development of the central nervous
system (CNS). Indeed, four recent studies have reported that
mutations in CIT are responsible for some cases of primary
microcephaly in humans (Basit et al., 2016; Harding et al., 2016; Li
et al., 2016; Shaheen et al., 2016), thereby, further supporting this
hypothesis and, for the first time, linking CIT-K to human disease.
In both rodents and humans, the defects in CNS development were
associated with failure of cytokinesis and severe apoptosis.
Mutations of CIT that were found to be associated with human
microcephaly mapped to different locations within the gene, and
included point mutations in conserved amino acids and splice sites,
as well as deletions (Basit et al., 2016; Harding et al., 2016; Li et al.,
2016; Shaheen et al., 2016). Some of the mutations identified in the
kinase domain abolish the kinase activity of CIT-K in vitro (Li et al.,
2016), clearly indicating that the kinase activity is essential for brain
development and cytokinesis. The CIT-K-binding partner ASPM is
one of the most frequently mutated genes in autosomal-recessive
human microcephaly and one of the main determinants of human
brain size (Nicholas et al., 2009), suggesting that a common cellular
mechanism underlies the cause of primary microcephaly. The
presence of multinucleated neurons in patients carrying CIT
mutations (Harding et al., 2016; Li et al., 2016) and the
established roles for both CIT-K and ASPM in cytokinesis
(Higgins et al., 2010; Paramasivam et al., 2007) suggest that
cytokinesis failure and, consequently, apoptosis is one such
possible mechanism. However, as both proteins also cooperate in
spindle orientation (Gai et al., 2016), defects during this step of
mitosis cannot be discounted as a possible cause.
Chromosomal instability (CIN) is a hallmark of many cancers
(Hanahan and Weinberg, 2011) and is characterized by recurrent
chromosomal changes that contribute to tumorigenesis by altering
the balance of critical growth and death pathways. CIN has been
implicated in cancer evolution, diversification and heterogeneity,
drug resistance, as well as in the development of metastases (Heng
et al., 2013; McGranahan et al., 2012). CIN often originates from
cell division defects and, therefore, a potential anti-cancer strategy
could be to increase aneuploidy and polyploidy above the thresholds
that are compatible with cell viability by interfering with cell
division in cancer cells (McGranahan et al., 2012). Furthermore,
P
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Fig. 4. Model for crossregulation between CIT-K and the chromosomal passenger complex (CPC) during cytokinesis. (A,B) The images on the left show
HeLa cells stained to detect the CPC kinase component Aurora B (red), CIT-K (green) and DNA (blue). CIT-Kmarks the cleavage furrow in A and themidbody ring
in B. Note that, although not evident in the image shown in A, Aurora B and CIT-K are also known to colocalise at the cleavage furrow (McKenzie et al., 2016).
Scale bars: 10 µm. (A). During early telophase, Aurora B-mediated phosphorylation of the CC1 domain of CIT-K prevents its interaction with centralspindlin and its
accumulation of at the spindle midzone. This allows the clustering of centralspindlin, which is promoted by phosphorylation of Aurora B. At the same time, Aurora
B-mediated phosphorylation of the CC1 domain within CIT-K could promote its association with the plasma membrane. (B) During late telophase, Aurora B
accumulates at themidbody arms, whereasCIT-K andMKLP1 localise to the Flemming body. This different localization would reduce the influence of Aurora B on
both CIT-K and MKLP1, so the two proteins can strongly interact to stabilize the midbody. Red arrows indicate phosphorylation.
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such a strategy would specifically target highly proliferating CIN
cancer cells and, thus, be potentially less toxic for normal tissues.
Following this line of thought and because CIT-K had been
indicated to be a potential target in hepatocellular carcinoma
(Fu et al., 2011), my lab recently investigated the depletion of CIT-
K as a a strategy to promote cell death in cancer cells. Indeed, we
found that CIT-K depletion caused failure of cytokinesis and
dramatically decreased cell proliferation in a large panel of breast,
cervical and colorectal cancer cell lines. This proliferation decrease
directly correlated with an increase in apoptosis via both p53-
dependent and -independent pathways. Finally, we have also shown
that actively dividing and polyploid cancer cells are more
susceptible to CIT-K depletion, suggesting that targeting CIT-K is
a promising anti-cancer therapeutic approach for a wide range of
cancers, especially those that are characterized by rapid cell
proliferation and polyploidy (McKenzie and D’Avino, 2016).
However, it is important to note that CIT-K loss can cause CIN
owing to its involvement in DNA damage control and
independently of its role in cytokinesis (Bianchi et al., 2017).
This raises the possibility that the effects on cancer cells upon CIT-
K depletion result from a combination of cytokinesis failure and
increased DNA damage.
Taken together, these findings clearly indicate a crucial role for
CIT-K in mammalian CNS development and point to its potential
targeting for anticancer therapy. A detailed knowledge of the
mechanisms of action of this kinase is, therefore, likely to lead to the
identification of new molecules and pathways that could be used for
the diagnosis and treatment of human diseases.
The importance of the kinase activity of CIT-K
There has been some debate over the last years with regard to the
role and physiological relevance of the kinase activity of CIT-K.
Initial studies indicated that the isolated kinase domain of CIT-K is
active in vitro (Di Cunto et al., 1998), and the first clue that its kinase
activity might be a physiologically relevant role came from the
analysis of the mouse gene knockout (Di Cunto et al., 2000; Di
Cunto et al., 2002). As mentioned earlier, the mouse CIT gene
encodes two different proteins, CIT-K and CIT-N, with the latter
lacking the kinase domain (Di Cunto et al., 1998; Madaule et al.,
1998). Already some time ago, Di Cunto et al. generated a knockout
mouse mutant carrying an insertion that specifically affected CIT-K,
without altering the expression of CIT-N (Di Cunto et al., 2000).
CIT-K−/− mice show abnormal CNS development and defects in
spermatogenesis (Di Cunto et al., 2000; Di Cunto et al., 2002),
supporting an in vivo function for the kinase activity of CIT-K.
However, because CIT-K and CIT-N do not show identical
expression patterns (Di Cunto et al., 2000), it was impossible to
extrapolate the exact role of the kinase activity of CIT-K from these
experiments. Further support for a physiological role of the kinase
activity of CIT-K came from observations that a kinase-dead mutant
cannot rescue the defects caused by depletion of endogenous CIT-
K, such as cytokinesis failure, midbody organisation and spindle
orientation, in both Drosophila and human cells (Bassi et al., 2011;
Gai et al., 2016; McKenzie et al., 2016). By contrast, other groups
reported, instead, that the kinase activity of CIT-K is not necessary
for cytokinesis in Drosophila and human cells (El Amine et al.,
2013; Watanabe et al., 2013). However, in their study, Watanabe
et al. reported that a kinase-dead CIT-K mutant only partially
rescues the multinucleate phenotype caused by depletion of
endogenous CIT-K (Watanabe et al., 2013), indicating that the
kinase activity of CIT-K is necessary for some functions in
cytokinesis. Although these contradictory reports had cast some
doubts on the physiological relevance of the kinase activity of
CIT-K, the more recent findings, implying impaired kinase activity
in microcephaly and cytokinesis failure in humans (Li et al., 2016),
convincingly demonstrate the in vivo importance of this particular
function of CIT-K.
Thus, because the vast majority of data strongly support a
physiological role for the kinase activity of CIT-K, any
discrepancies amongst studies might simply reflect differences in
techniques and/or methodologies used.
Conclusions and future perspectives
The story of CIT-K exemplifies and emphasises how important it
is in science to have an open mind and to think ‘outside the box’.
The initial but, later found to be incorrect, model positing a role for
CIT-K as a Rho effector that promotes the constriction of the
actomyosin ring during cytokinesis (Madaule et al., 1998, 2000;
Yamashiro et al., 2003), might have hindered efforts to further
characterise the multiple roles and mechanisms of action of this
important kinase (Fig. 1) because the cellular function of CIT-K
was assumed to have been established, with it only playing an
ancillary role in cytokinesis. I hope that this Commentary will
serve to ‘rehabilitate’ and re-evaluate this important kinase, and
also eliminate the misconception that CIT-K is required for the
constriction of the actomyosin ring − which is still present in the
scientific community. Undoubtedly, the recent studies are likely to
stimulate the interest of the scientific community in CIT-K.
Indeed, there are a number of questions that remain to be answered.
First and foremost, we need to identify the substrates and partners
of CIT-K at different stages of the cell cycle to fully understand its
mechanisms of action. Only a single bona fide CIT-K substrate has
been identified thus far and the CIT-K interactome has only been
characterised during telophase (McKenzie et al., 2016). Second, it
will be important to establish tools, such as small-molecule
inhibitors and analogue-sensitive mutants, to address the role of its
kinase activity in vivo. Third, we do not know why CIT-K is
necessary in every tissue in fly (D’Avino et al., 2004; Naim et al.,
2004; Shandala et al., 2004), whereas it appears to be more
important for the normal development and function of the CNS in
mammals (Basit et al., 2016; Di Cunto et al., 2000, 2002; Harding
et al., 2016; Li et al., 2016; Shaheen et al., 2016), despite the fact
that its depletion causes cytokinesis failure in different types of
human cultured cell (McKenzie and D’Avino, 2016). This
discrepancy between in vivo an ex vivo model systems might
simply reflect a difference in the requirement of CIT-K and
midbody formation in cultured cells versus whole tissues. Another
possibility is that some tissues are more sensitive than others to the
loss of CIT-K. For instance, Sgrò et al. proposed recently that the
expression of the tissue-specific tubulin variant TUBB3 sensitizes
cultured neuronal progenitors to CIT-K loss (Sgrò et al., 2016);
however, we could not find a correlation between TUBB3
expression and CIT-K depletion in various cancer cell lines
(McKenzie and D’Avino, 2016). It is also important to point out
that CIT-K is involved in both spindle orientation and midbody
formation, two events that have been implicated in establishing
cell fate and polarity (Bergstralh and St Johnston, 2014; Dionne
et al., 2015). Therefore, it would be interesting to know whether
CIT-K functions in yet more biological processes, such as
stemness, differentiation, and tissue organization and
remodelling. Last, there is evidence that CIT-K has other roles
besides in cell division. In addition to its recently described role in
DNA damage (Bianchi et al., 2017), CIT-K has also been
proposed to function in virus budding, organization of the Golgi
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complex and epigenetic gene silencing (Camera et al., 2003; Ding
et al., 2016; Loomis et al., 2006; Sweeney et al., 2008) but, as yet,
there are no major insights into its mechanisms of action in these
processes.
There is clearly still much work to do before we fully understand
this complex and multifunctional kinase but, hopefully, the
discussion in this Commentary contributes to raising the profile of
this fascinating but understudied kinase, and sparks interest in
studying its roles more extensively in the future.
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